Biotech investors in Germany
Updated 16 Nov 2026
Venture funds
4 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) HTGF invests across various sectors, with recent investments including Rabot Energy and CereGate. Bonn, Germany |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 28% | 5 |
| 2 | BlueYard Capital BlueYard Capital invests in founders with ideas that decentralize markets, with recent investments in Castelion and Cryptio. Berlin, Germany |
Fintech, Biotech | Seed, Early stage venture | 41% | 3 |
| 3 | Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix. Ingelheim Am Rhein, Germany |
Biotech, Health care | Seed, Early stage venture | 47% | 3 |
| 4 | Nucleus Capital Nucleus Capital backs frontier founders, with recent companies Apoha and Biomia. Berlin, Germany |
Biotech, Health care | Seed, Early stage venture | 32% | 2 |
Table 1. Biotech investors in Germany: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | •••@htgf.de | +49 22••• |
| KfW | Government investment office | Frankfurt, Germany | •••@kfw.de | 49 69 ••• |
| Bayern Kapital | Venture capital firm | Landshut, Germany | •••@bayernkapital.de | +49871••• |
| Wellington Partners | Venture capital firm | Munich, Germany | •••@wellington-partners.com | +44 20••• |
| NRW.BANK | Government investment office | Düsseldorf, Germany | •••@nrwbank.de | +32 2 ••• |
| MIG Capital | Venture capital firm | Munich, Germany | •••@mig.ag | |
| German Federal Ministry of Research, Technology and Space | Government investment office | Bonn, Germany | •••@bmftr.bund.de | +49 (0••• |
| Fraunhofer Venture | Venture capital firm | Munich, Germany | •••@fraunhoferventure.de | +49 89••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 44 of the 60 biotech investors in Germany have a published email address, 39 a phone number and 59 a website.
- HTGF (High-Tech Gruenderfonds) has the most recorded investments, 1,026, 290 of them as lead investor.
- 39 of them are investors in at least one company that closed its most recent round in the last 12 months.
- HTGF (High-Tech Gruenderfonds) is an investor in 17 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Zafrens' $6.0M Series A on 3 November 2026.
- Software is the most common sector across their 1,222 portfolio companies (68%).
- Early stage venture is the most common investment stage, recorded for 54 of them (90%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in Germany
30 of 60, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | Biotech, Health care | Rabot Energy, CereGate, syte | 17 | 1,026 | 290 | 136 | •••@htgf.de | +49 22••• | In the CSV |
| 2 | KfW | Government investment office, Investment bank | Frankfurt, Germany | Biotech, Health care | CryoTherapeutics, Vectoflow, HelloDuty | 198 | 29 | 56 | •••@kfw.de | 49 69 ••• | In the CSV | |
| 3 | Bayern Kapital | Venture capital firm | Landshut, Germany | Health care, Artificial intelligence | mbiomics, SPiNE, Driveblocks | 4 | 294 | 41 | 41 | •••@bayernkapital.de | +49871••• | In the CSV |
| 4 | Boehringer Ingelheim Venture Fund | Corporate venture arm | Ingelheim Am Rhein, Germany | Biotech, Health care | smartbax, xCures, Tacalyx | 4 | 99 | 47 | 12 | +49 61••• | ||
| 5 | Wellington Partners | Venture capital firm | Munich, Germany | Health care, Biotech | nyra health | 1 | 252 | 80 | 65 | •••@wellington-partners.com | +44 20••• | In the CSV |
| 6 | NRW.BANK | Government investment office, Investment bank | Düsseldorf, Germany | Artificial intelligence, Biotech | Lumoview Building Analytics, Elixion Medical, Alteva | 126 | 28 | 17 | •••@nrwbank.de | +32 2 ••• | In the CSV | |
| 7 | MIG Capital | Venture capital firm | Munich, Germany | Biotech, Health care | NavVis, mbiomics | 2 | 95 | 43 | 15 | •••@mig.ag | In the CSV | |
| 8 | Leaps by Bayer | Corporate venture arm | Leverkusen, Germany | Health care, Biotech | 9amHealth, CORXEL Pharmaceuticals | 2 | 113 | 45 | 13 | In the CSV | ||
| 9 | BlueYard Capital | Venture capital firm | Berlin, Germany | Fintech, Biotech | Zafrens, Castelion, Transcripta Bio | 7 | 102 | 42 | 4 | +49 61••• | In the CSV | |
| 10 | German Federal Ministry of Research, Technology and Space | Government investment office | Bonn, Germany | Biotech, Health care | eClear, NVision Quantum Technologies | 2 | 62 | 39 | 13 | •••@bmftr.bund.de | +49 (0••• | In the CSV |
| 11 | Fraunhofer Venture | Venture capital firm | Munich, Germany | Biotech, Health care | Cellbox Solutions | 1 | 40 | 6 | 5 | •••@fraunhoferventure.de | +49 89••• | In the CSV |
| 12 | Possible Ventures | Venture capital firm | Munich, Germany | Hardware, Artificial intelligence | Antaris, Arlula, InSpacePropulsion Technologies | 4 | 152 | 9 | 9 | In the CSV | ||
| 13 | IFB Innovationsstarter | Venture capital firm | Hamburg, Germany | Health care, Biotech | recalm, apoQlar, SupplyET | 88 | 35 | 6 | +49 40••• | In the CSV | ||
| 14 | LBBW VC | Corporate venture arm | Stuttgart, Germany | Biotech, Health care | Exciva | 1 | 47 | 14 | 7 | +49 71••• | In the CSV | |
| 15 | Nucleus Capital | Venture capital firm | Berlin, Germany | Biotech, Health care | Apoha, Biomia | 2 | 44 | 14 | 2 | In the CSV | ||
| 16 | Amino Collective | Venture capital firm | Berlin, Germany | Health care, Biotech | Tandem Health, Rivia, Biomia | 3 | 42 | 2 | 2 | •••@aminocollective.com | In the CSV | |
| 17 | EMBL Ventures | Venture capital firm | Heidelberg, Germany | Biotech, Health care | Luxendo, Allecra Therapeutics, ImevaX | 20 | 5 | 6 | •••@embl-ventures.com | +49 (6••• | In the CSV | |
| 18 | b.value AG | Venture capital firm | Dortmund, Germany | Biotech, Health care | Cellbricks Therapeutics | 1 | 13 | 3 | 0 | •••@b-value.de | +49 (0••• | In the CSV |
| 19 | Earlybird Venture Capital | Venture capital firm | Berlin, Germany | Artificial intelligence, Fintech | finmid, ColibrITD, Quantum Diamonds | 7 | 348 | 143 | 59 | +49 30••• | In the CSV | |
| 20 | bmp Ventures | Venture capital firm | Berlin, Germany | Health care, Biotech | RAYDIAX | 1 | 123 | 49 | 20 | •••@bmp.com | + 49- ••• | In the CSV |
| 21 | BASF Venture Capital | Corporate venture arm | Ludwigshafen, Germany | Biotech, Artificial intelligence | Computomics | 1 | 88 | 35 | 18 | 973 24••• | In the CSV | |
| 22 | Brandenburg Kapital | Government investment office, Venture capital firm | Potsdam, Germany | Biotech, Energy | Kupando | 1 | 73 | 31 | 7 | •••@ilb.de | +49 33••• | In the CSV |
| 23 | Think.Health | Venture capital firm | Fürstenfeldbruck, Germany | Health care, Biotech | Sphingotec GmbH, Myo, Vara | 33 | 12 | 4 | •••@think-health.de | |||
| 24 | Picus Capital | Venture capital firm | Munich, Germany | Fintech, Artificial intelligence | Reflex, Baselayer, FINN | 8 | 337 | 68 | 18 | •••@picuscap.com | +49 89••• | In the CSV |
| 25 | IBB Ventures | Venture capital firm | Berlin, Germany | Artificial intelligence, Health care | Ascléa, ARC Intelligence, Qdrant | 3 | 265 | 49 | 43 | •••@ibbventures.de | 030 - ••• | In the CSV |
| 26 | APX | Venture capital firm | Berlin, Germany | Artificial intelligence, Fintech | VisioLab | 1 | 182 | 50 | 10 | •••@apx.vc | ||
| 27 | TGFS - Technologiegründerfonds Sachsen | Venture capital firm | Leipzig, Germany | Artificial intelligence, Hardware | Prodlane, BirdsView, Peeriot | 4 | 160 | 36 | 11 | •••@tgfs.de | +49341••• | In the CSV |
| 28 | UVC Partners | Venture capital firm | Garching, Germany | Artificial intelligence, Biotech | Reel Energy, Synera, Rencore | 3 | 129 | 50 | 13 | •••@uvcpartners.com | In the CSV | |
| 29 | eCAPITAL ENTREPRENEURIAL PARTNERS | Venture capital firm | Münster, Germany | Biotech, Cybersecurity | Ferroelectric Memory Company, Papershift, envelio | 122 | 84 | 25 | •••@ecapital.vc | +49 (0••• | In the CSV | |
| 30 | coparion | Startup accelerator | Cologne, Germany | Biotech, Hardware | Tacalyx | 1 | 96 | 5 | 15 | •••@coparion.vc | +49 30••• | In the CSV |
Table 2. Biotech investors in Germany: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 60.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Bonn, Germany | 17 | 257 | Rabot Energy, CereGate, syte |
| 2 | Picus Capital | Munich, Germany | 8 | 69 | Reflex, Baselayer, FINN |
| 3 | BlueYard Capital | Berlin, Germany | 7 | 25 | Zafrens, Castelion, Transcripta Bio |
| 4 | Earlybird Venture Capital | Berlin, Germany | 7 | 72 | finmid, ColibrITD, Quantum Diamonds |
| 5 | Cherry Ventures | Berlin, Germany | 7 | 58 | Moss, Stenon, bunch |
| 6 | Leblon Capital | Munich, Germany | 5 | 38 | Mural, Rivio, Taktile |
| 7 | HV Capital | Munich, Germany | 5 | 72 | Rabot Energy, FINN, NEURA Robotics |
| 8 | TGFS - Technologiegründerfonds Sachsen | Leipzig, Germany | 4 | 22 | Prodlane, BirdsView, Peeriot |
| 9 | Boehringer Ingelheim Venture Fund | Ingelheim Am Rhein, Germany | 4 | 14 | smartbax, xCures, Tacalyx |
| 10 | Bayern Kapital | Landshut, Germany | 4 | 69 | mbiomics, SPiNE, Driveblocks |
| 11 | Possible Ventures | Munich, Germany | 4 | 36 | Antaris, Arlula, InSpacePropulsion Technologies |
| 12 | SquareOne Venture Capital | Berlin, Germany | 3 | 22 | Procuros, Zuriq, Graph Therapeutics |
| 13 | Amino Collective | Berlin, Germany | 3 | 11 | Tandem Health, Rivia, Biomia |
| 14 | IBB Ventures | Berlin, Germany | 3 | 62 | Ascléa, ARC Intelligence, Qdrant |
| 15 | UVC Partners | Garching, Germany | 3 | 26 | Reel Energy, Synera, Rencore |
Table 3. Biotech investors in Germany: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Zafrens | Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. | Biotech | San Diego, United States | Series A | $6.0M | 2026-11-03 | $35.0M | BlueYard Capital | 11 to 50 | 2022 |
| Reflex | Reflex is an open-source Python framework for building and deploying web applications. | Software | San Francisco, United States | Series A | $14.0M | 2026-10-29 | $19.5M | Picus Capital | 11 to 50 | 2023 |
| Mural | Mural offers a financial platform for cross-border payments, fund transfers, and digital asset transactions. | Fintech | New York, United States | Series A | $15.0M | 2026-10-20 | $20.6M | Leblon Capital | 11 to 50 | 2022 |
| Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne, Germany | Series A | $1.7M | 2026-10-20 | $15.3M | Fraunhofer Venture | 11 to 50 | 2017 |
| Rabot Energy | Rabot Energy supplies green electricity with flexible and smart tariffs for homes and electric vehicles. | Energy | Hamburg, Germany | Series B | $56.1M | 2026-10-14 | $79.7M | HV Capital, HTGF (High-Tech Gruenderfonds) | 101 to 250 | 2021 |
| finmid | finmid provides embedded lending infrastructure that powers platform growth. | Fintech | Berlin, Germany | Series A | $19.1M | 2026-10-06 | $58.0M | Earlybird Venture Capital | 11 to 50 | 2021 |
| Procuros | Procuros is a fintech company that automates manual B2B transactions into transparent flows. | Fintech | Hamburg, Germany | Series A | $22.3M | 2026-10-05 | $32.5M | SquareOne Venture Capital | 11 to 50 | 2021 |
| Baselayer | Baselayer automates risk assessment and fraud detection for financial and government institutions. | Artificial intelligence | New York, United States | Series A | $35.0M | 2026-09-22 | $82.0M | Picus Capital | 51 to 100 | 2024 |
| syte | Syte uses AI to analyze property data and help real estate buyers judge development potential and economic viability. | Artificial intelligence | Münster, Germany | Series A | $10.3M | 2026-09-17 | $19.2M | HTGF (High-Tech Gruenderfonds) | 11 to 50 | 2021 |
| Tandem Health | Tandem Health develops AI tools for clinical documentation, coding, decision support, and follow-up in healthcare. | Artificial intelligence | Stockholm, Sweden | Series B | $100.0M | 2026-09-14 | $159.7M | Amino Collective | 101 to 250 | 2023 |
Table 4. Biotech investors in Germany: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 832 | 68% |
| Artificial intelligence | 260 | 21% |
| Health care | 238 | 19% |
| Biotech | 208 | 17% |
| Hardware | 163 | 13% |
| Fintech | 163 | 13% |
| Commerce | 110 | 9% |
| Education | 40 | 3% |
| Energy | 37 | 3% |
| Cybersecurity | 32 | 3% |
Table 5. Biotech investors in Germany: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 54 | 90% |
| Seed investors | 47 | 78% |
| Late stage investors | 28 | 47% |
| Venture investors | 26 | 43% |
| Private equity investors | 6 | 10% |
| Debt investors | 5 | 8% |
| Convertible note investors | 5 | 8% |
| Post IPO investors | 3 | 5% |
Table 6. Biotech investors in Germany by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech investors in Germany by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 3 | 5% |
| 2010s | 19 | 34% |
| 2000s | 19 | 34% |
| 1990s | 9 | 16% |
| 1980s | 1 | 2% |
| 1970s | 2 | 4% |
Table 8. Biotech investors in Germany by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in Germany. On 16 November 2026 that is 60 investors.
- 44 rows carry an email address and 39 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 60 rows: 1 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in Germany are on the list?
- 60, in the file dated 16 November 2026. 39 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 44 of the 60 carry an email address in the download and 39 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 60 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 60 rows, 44 firm email addresses and 39 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 35 of the 44 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.